28.1 USD
+0.47 (+1.7%)
CHSCP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. CHSCP has a bad profitability rating. Also its financial health evaluation is rather negative. CHSCP has a expensive valuation and it also scores bad on growth. CHSCP also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
CHSCP had a positive operating cash flow in the past year.
CHSCP had positive earnings in each of the past 5 years.
In the past 5 years CHSCP always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 3.17%, CHSCP perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.40%, CHSCP is in line with its industry, outperforming 51.72% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.49%, CHSCP is doing worse than 62.07% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHSCP is significantly below the industry average of 28.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROIC | 0.49% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
With a Profit Margin value of 1.69%, CHSCP perfoms like the industry average, outperforming 47.13% of the companies in the same industry.
CHSCP's Profit Margin has improved in the last couple of years.
CHSCP's Operating Margin of 0.26% is on the low side compared to the rest of the industry. CHSCP is outperformed by 63.22% of its industry peers.
In the last couple of years the Operating Margin of CHSCP has declined.
CHSCP's Gross Margin of 3.21% is on the low side compared to the rest of the industry. CHSCP is outperformed by 89.66% of its industry peers.
In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCP is destroying value.
Compared to 1 year ago, CHSCP has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.32 indicates that CHSCP is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHSCP has a Altman-Z score (2.32) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.26 indicates that CHSCP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.26, CHSCP is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.32 |
ROIC/WACC0.09
WACC5.56%
2.3 Liquidity
A Current Ratio of 1.53 indicates that CHSCP should not have too much problems paying its short term obligations.
CHSCP has a Current ratio of 1.53. This is comparable to the rest of the industry: CHSCP outperforms 43.68% of its industry peers.
CHSCP has a Quick Ratio of 1.53. This is a bad value and indicates that CHSCP is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCP has a Quick ratio (0.91) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Revenue has decreased by -9.68% in the past year.
The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCP indicates a rather cheap valuation: CHSCP is cheaper than 91.95% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.49 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.02%, CHSCP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.37, CHSCP pays a better dividend. On top of this CHSCP pays more dividend than 94.25% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CHSCP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.02% |
5.2 History
CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
CHSCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
5.3 Sustainability
28.20% of the earnings are spent on dividend by CHSCP. This is a low number and sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCP (12/19/2025, 8:00:00 PM)
28.1
+0.47 (+1.7%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners11.45%
Inst Owner Change0.8%
Ins Owners0.04%
Ins Owner Change0%
Market Cap344.79M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.04%
Short Ratio0.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.02% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years21
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.54 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.49 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY184.4%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROCE | 0.67% | ||
| ROIC | 0.49% | ||
| ROICexc | 0.5% | ||
| ROICexgc | 0.5% | ||
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.9 | ||
| Cap/Depr | 111.84% | ||
| Cap/Sales | 2.05% | ||
| Interest Coverage | 0.62 | ||
| Cash Conversion | 85.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.56%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 8 PERP / CHSCP FAQ
What is the fundamental rating for CHSCP stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.
What is the valuation status for CHSCP stock?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.
Can you provide the profitability details for CHS INC - CHSINC 8 PERP?
CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 3 / 10.
How financially healthy is CHS INC - CHSINC 8 PERP?
The financial health rating of CHS INC - CHSINC 8 PERP (CHSCP) is 3 / 10.